Today: 21 May 2026
Boeing stock ticks up as investors brace for Tuesday’s delivery report after Airbus update
12 January 2026
1 min read

Boeing stock ticks up as investors brace for Tuesday’s delivery report after Airbus update

New York, January 12, 2026, 12:16 EST — Market open for the regular session.

  • Boeing shares climbed roughly 1.4% by midday.
  • Airbus released its delivery and order numbers for 2025; Boeing is set to report its full-year totals on Tuesday.
  • The FAA has put forward a new inspection rule targeting specific Boeing 737NG models, with a comment deadline set for Feb. 26.

Boeing shares climbed Monday, building on recent momentum ahead of the company’s annual orders-and-deliveries report set for Tuesday. By midday in New York, the stock had gained roughly 1.4%, trading at $237.72.

The delivery tally is key since Boeing typically receives payment upon handing over jets to customers. A strong result can ease concerns about production and cash flow, especially as traders adjust positions following Airbus’s release of its 2025 figures.

Airbus reported a 4% increase in 2025 deliveries, hitting 793 aircraft, alongside 1,000 gross orders, which trimmed down to 889 net after cancellations. Boeing, set to release its full-year figures Tuesday, delivered 537 jets and secured 1,000 gross orders, or 908 net, from January through November, according to the Airbus disclosure.

Much attention centers on the run rate. Investors are eyeing if December handovers shifted the momentum heading into 2026, and whether cancellations sliced the headline order count.

Regulators have introduced new paperwork targeting older Boeing narrowbodies. The FAA proposed an airworthiness directive—a safety mandate that can require inspections and fixes—for Boeing 737NG planes following reports of cracks in the outboard lower wing skin. If approved, this would impact 1,857 U.S.-registered aircraft. The deadline for comments is Feb. 26.

Boeing’s leadership has zeroed in on deliveries as the key to turning cash flow positive. At a UBS conference in December, CFO Jay Malave said the company expects free cash flow in 2026—what’s left after operating expenses and investments—to finally move into positive territory. He also noted, “Big picture, we expect deliveries both on the 737 and the 787 to grow.” Reuters

The downside scenario is clear: Tuesday’s numbers might reveal a slower handover pace than what the stock currently prices in, or an uptick in cancellations that weakens the order story. Any fresh quality issues or supplier hiccups delaying deliveries would also undermine the cash narrative.

Airbus’ figures highlighted the ongoing competitive gap. Boeing’s upcoming update will reveal if it managed to close that gap by year-end, despite ongoing challenges with production limits and parts shortages.

Upcoming catalysts are just around the corner. Boeing will release its full-year orders and deliveries figures on Tuesday, Jan. 13, followed by its fourth-quarter earnings report on Jan. 27.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Affirm stock gives up premarket pop after Trump backs 10% credit-card rate cap
Previous Story

Affirm stock gives up premarket pop after Trump backs 10% credit-card rate cap

Dow Jones today: Index slips as Trump’s 10% credit-card cap hits banks, Powell subpoena clouds the Fed
Next Story

Dow Jones today: Index slips as Trump’s 10% credit-card cap hits banks, Powell subpoena clouds the Fed

Go toTop